Can Wells Fargo, Boeing and Biogen Add Value?
October 27, 2020 at 18:20 PM EDT
By Brandon Rakszawski, VanEck Senior ETF Product Manager I’ve written frequently about market valuation in recent months, and for good reason. It’s no secret that a small number of stocks have accounted for a disproportionate amount of the market’s return. More and more U.S. stock investors are facing a difficult decision: do you stay on benchmark and seek little or no alpha, or do you underweight mega-cap, big tech stocks in favor of other potential opportunities in the market?
